Free. Unsubscribe any time.
Maze Therapeutics, Inc. (MAZE)
Maze Therapeutics, Inc. filed 35 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 4 reporting owners, covering 73 transactions and 578,956 shares. None carries the SEC's AFF10B5ONE flag; all 35 name a plan in a footnote. No results print is on file in this window, so no interval is measured.
What stands out
- The most recent filing on file, dated 2026-09-08, came 5 days after the one before it (2026-09-03) and reports 1 transaction against 5 in the filing before it.
- The sales it reports total 9,705 shares, 6,436 fewer than the 16,141 in the filing before it.
- Its 35 filings on file run from 2025-12-31 to 2026-09-08, and state 2 plan adoption dates, from 2025-09-29 to 2026-02-06.
Trades in Maze Therapeutics, Inc. 73
- Bachrodt Amy — 2025-12-29 · S · 9,400 shares
- Bachrodt Amy — 2025-12-29 · S · 600 shares
- Bernstein Harold — 2025-12-29 · S · 27,800 shares
- Bernstein Harold — 2025-12-29 · S · 17,200 shares
- Dandekar Atul — 2025-12-29 · S · 66,365 shares
- Dandekar Atul — 2025-12-29 · S · 6,035 shares
- Bachrodt Amy — 2025-12-30 · S · 5,000 shares
- Dandekar Atul — 2025-12-30 · S · 100 shares
- Bachrodt Amy — 2026-01-02 · S · 2,405 shares
- Bachrodt Amy — 2026-01-02 · S · 2,595 shares
- Bernstein Harold — 2026-01-02 · S · 4,432 shares
- Bernstein Harold — 2026-01-05 · S · 412 shares
Adoption dates in Maze Therapeutics, Inc. 2
- 2025-09-29 — stated in 28 filings
- 2026-02-06 — stated in 7 filings
Results prints in Maze Therapeutics, Inc. 0
Trades before a print in Maze Therapeutics, Inc. 0
Interval to Maze Therapeutics, Inc.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- —shortest, days
- 73no later print
Adoption dates Maze Therapeutics, Inc. states
- 2025-09-29 in 28 filings
- 2026-02-06 in 7 filings
Filing text: “10b5-1 trading plan adopted by the reporting person on February 6, 2026”
Sources: SEC EDGAR full-text search and the SEC submissions API.